Suresh Shelat, based in New York, New York, United States, is currently a Immuno-Oncology Cellular Therapy Clinical Development, Sr Director at Bristol Myers Squibb, bringing experience from previous roles at Sanofi, Bristol-Myers Squibb, Penn Medicine, University of Pennsylvania Health System and Children's Hospital of Philadelphia. Suresh Shelat holds a MD, PhD @ University of Pennsylvania School of Medicine. With a robust skill set that includes Medical Research, Clinical Trials, Medical Writing, Translational Medicine, Public Speaking and more, Suresh Shelat contributes valuable insights to the industry. Suresh Shelat has 3 emails and 1 mobile phone number on RocketReach.